Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway

We performed cell and animal experiments to explore the therapeutic effect of artemisinin on Parkinson's disease (PD) and the TLR4/Myd88 signaling pathway.

• Publication year

  2023

• Venue

  CNS Neuroscience & Therapeutics

• Publication date

  2023-01-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cns.14063PMID 36691817PMCID 10018080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway

  2023cited by this paper
• Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho

  2022cited by this paper
• Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease

  2022cited by this paper
• Nano-organization of spontaneous GABAergic transmission directs its autonomous function in neuronal signaling

  2022cited by this paper
• Transplantation of Roxadustat‐preconditioned bone marrow stromal cells improves neurological function recovery through enhancing grafted cell survival in ischemic stroke rats

  2022cited by this paper
• CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease

  2021cited by this paper
• Interaction of artemisinin protects the activity of antioxidant enzyme catalase: A biophysical study.

  2021cited by this paper
• Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets

  2021cited by this paper
• Promising drug targets and associated therapeutic interventions in Parkinson’s disease

  2021cited by this paper
• Oxidative stress and regulated cell death in Parkinson's disease.

  2021cited by this paper
• Artemisinin improves neurocognitive deficits associated with sepsis by activating the AMPK axis in microglia

  2021cited by this paper
• Sensory Neuron TLR4 mediates the development of nerve-injury induced mechanical hypersensitivity in female mice.

  2021cited by this paper
• Parkinson disease-associated cognitive impairment

  2021cited by this paper
• Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis

  2021cited by this paper
• Critical Roles of Lysophospholipid Receptors in Activation of Neuroglia and Their Neuroinflammatory Responses

  2021cited by this paper
• Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti‐inflammatory microglia/macrophages phenotype polarization through GSK‐3β/Nrf2 pathway

  2021cited by this paper
• Immune cell compartmentalization for brain surveillance and protection

  2021cited by this paper
• FBXO10 prevents chronic unpredictable stress‐induced behavioral despair and cognitive impairment through promoting RAGE degradation

  2021cited by this paper
• TLR4 and AT1R mediate blood-brain barrier disruption, neuroinflammation, and autonomic dysfunction in spontaneously hypertensive rats.

  2021cited by this paper
• Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption

  2021cited by this paper
• Therapeutic Potential of Vital Transcription Factors in Alzheimer’s and Parkinson’s Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy

  2021cited by this paper
• OUP accepted manuscript

  2021cited by this paper
• Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state

  2021cited by this paper
• Epithelial TLR4 signaling activates DUOX2 to induce microbiota-driven tumorigenesis.

  2020cited by this paper
• Artemisinin attenuated oxidative stress and apoptosis by inhibiting autophagy in MPP+-treated SH-SY5Y cells

  2020cited by this paper
• Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.

  2020cited by this paper
• Mucuna pruriens in Parkinson’s and in some other diseases: recent advancement and future prospective

  2020cited by this paper
• Advancement in the modelling and therapeutics of Parkinson's disease.

  2020cited by this paper
• Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease.

  2020cited by this paper
• Association of inflammatory factors and aging in Parkinson's disease.

  2020cited by this paper
• Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons

  2020cited by this paper
• Transcriptomic and clonal characterization of T cells in the human central nervous system

  2020cited by this paper
• Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases

  2020cited by this paper
• Focal TLR4 activation mediates disturbed flow-induced endothelial inflammation.

  2019cited by this paper
• Canadian guideline for Parkinson disease

  2019cited by this paper
• Impaired cellular bioenergetics caused by GBA1 depletion sensitizes neurons to calcium overload

  2019cited by this paper
• Negative regulation of glial Tim‐3 inhibits the secretion of inflammatory factors and modulates microglia to antiinflammatory phenotype after experimental intracerebral hemorrhage in rats

  2019cited by this paper
• Farrerol attenuates MPP+‐induced inflammatory response by TLR4 signaling in a microglia cell line

  2019cited by this paper
• Transplantation of Nurr1‐overexpressing neural stem cells and microglia for treating parkinsonian rats

  2019cited by this paper
• TLR4 (Toll-Like Receptor 4) Mediates the Development of Intracranial Aneurysm Rupture

  2019cited by this paper
• Deficiency of TLR4 ameliorates hypoperfusion-induced brain pathology

  2018cited by this paper
• Artemisinin Prevents Glutamate-Induced Neuronal Cell Death Via Akt Pathway Activation

  2018cited by this paper
• Microglial TLR4-dependent autophagy induces ischemic white matter damage via STAT1/6 pathway

  2018cited by this paper
• Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway

  2017cited by this paper
• TLR4 Signaling in MPP+-Induced Activation of BV-2 Cells

  2016cited by this paper
• Microglia development and function.

  2014cited by this paper
• Toxicity of the antimalarial artemisinin and its dervatives

  2010cited by this paper

• Research progress on the interaction of artemisinin and its derivatives with TLR4 receptors in neuroinflammation.

  2025cites this paper
• Gentiopicroside alleviates neuroinflammation in Parkinson's disease by mediating microglial pyroptosis via the NF-κB/NLRP3/GSDMD pathway.

  2025cites this paper
• Artemisinin alleviates ischemic stroke injury and promotes neurogenesis through PPARγ-mediated M2 polarization of microglia.

  2025cites this paper
• Evaluation of vitamin D3 in intestinal damage of on-growing grass carp (Ctenopharyngodon idella): Mitochondrial homeostasis and inflammatory responses

  2025cites this paper
• Developmental and Neuroprotective Effects of α-Terpineol in MPTP-Induced Parkinsonism in Zebrafish Larvae

  2025cites this paper
• The relationship between increased levels of microbiota-derived lipopolysaccharide in obesity and the pathophysiology of neurodegenerative diseases.

  2025cites this paper
• Exosomes derived from baicalin-pretreated bone marrow mesenchymal stem cells inactivate the TLR4/MyD88/NF-kB pathway to improve asthma.

  2025cites this paper
• Isoquercetin mitigates neuroinflammation and oxidative stress by targeting the NF-κB pathway.

  2025cites this paper
• Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges

  2025cites this paper
• Artemisinin Alleviates Chronic Social Defeat Stress‐Induced Depressive‐Like Behavior by Inhibiting Neuroinflammation via the TLR4/MyD88/NF‐κB/NLRP3 Signaling Pathway

  2025cites this paper
• Regulatory mechanisms and therapeutic potential of natural microglia inhibitors in Parkinson's disease.

  2025cites this paper
• Dihydrotricetin from Euonymus hamiltonianus ameliorates neuroinflammation and exhibits neuroprotective effect in LPS-induced microglia.

  2025cites this paper
• Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway

  2024cites this paper
• What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?

  2024cites this paper
• Artemisinin reduces PTSD-like symptoms, improves synaptic plasticity, and inhibits apoptosis in rats subjected to single prolonged stress

  2024cites this paper
• Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation.

  2024cites this paper
• Functional modification of recombinant brain-derived neurotrophic factor and its protective effect against neurotoxicity.

  2024cites this paper
• Antimicrobial drugs for Parkinson's disease: existing therapeutic strategies and novel drugs exploration.

  2024cites this paper
• Dihydroartemisinin Modulates Enteric Glial Cell Heterogeneity to Alleviate Colitis

  2024cites this paper
• Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway

  2023cites this paper
• Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson's disease.

  2023cites this paper
• Investigating the TLR4/TAK1/IRF7 axis in NLRP3-Mediated Pyroptosis in Parkinson's Disease

  2023cites this paper
• Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases

  2023cites this paper
• Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway

  2023cites this paper
• Role of Microglial Metabolic Reprogramming in Parkinson's Disease.

  2023cites this paper